Shearman & Sterling advised Amyris on its joint venture with Ingredion Incorporated.
The agreement is for the exclusive licensing of Amyris’s zero-calorie, nature-based, fermented Reb M sweetener. The transaction value is estimated to be $100 million. This includes $75 million for the exclusive license to sell and market Reb M from fermentation plus a contribution for a participation in the Brazil manufacturing joint venture. Additionally, Amyris will earn a profit share from Reb M sales.
In addition, the agreement includes an Ingredion minority ownership stake in the Amyris Brazilian manufacturing facility that is currently under construction.
Amyris is a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients. Ingredion Incorporated is a leading global ingredient solutions provider to the food and beverage industry.
Shearman & Sterling advised Amyris with Michael Dorf (Picture), Larry Crouch, Jonathan Cheng, Zach Bench, Benjamin Petersen, Ruba Noorali, Adam Sternberg, JB Betker, Eugene Kang, and Austin Jones.
Involved fees earner: Zach Bench – Shearman & Sterling; JB Betker – Shearman & Sterling; Jonathan Cheng – Shearman & Sterling; Larry Crouch – Shearman & Sterling; Michael Dorf – Shearman & Sterling; Austin Jones – Shearman & Sterling; Eugene Kang – Shearman & Sterling; Ruba Noorali – Shearman & Sterling; Benjamin Petersen – Shearman & Sterling; Adam Sternberg – Shearman & Sterling;
Law Firms: Shearman & Sterling;
Clients: Amyris, Inc.;